Bayer faces second trial over alleged Roundup cancer risk

Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company’s share price was rocked by a $289 million verdict in California state court.


Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

10 + 6 =